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1. Introduction 
Colostral trypsin inhibitor plays an important 
role in the mechanism of absorption of immune 
bodies by a new-born mammal [ 1,2]. 
In human colostrum the content of the trypsin 
inhibitor is much lower than 5.1 the case of other 
mammals. This can be explained by different path- 
ways of antibody transfer: predominantly via pla- 
centa in man, via colostrum in other mammals [2]. 
The highest concentration of the inhibitor occurs 
in human colostrum between the 2nd and 3rd day 
[I, 31. 
Laskowski and Laskowski obtained a pure tryp- 
sin inhibitor preparation from bovine colostrum 
[4] . To facilitate the procedure of its isolation, 
they recommended later [l] as the first step a pre- 
cipitation of the bulk of proteins with 2.5% tri- 
chloroacetic acid at 80”) which causes a loss of 
approximately 75% of the total inhibitor. The in- 
hibitor resulting from this method has a molecular 
weight of 10,500, it is highly stable in acid media 
and at elevated temperature [ 1,5]. 
techova: et al. have determined its partial pri- 
mary structure and found that it is structurally re- 
lated to the basic inhibitor from bovine pancreas 
[6]. Recently the same authors have shown that 
the crude inhibitor preparation from bovine colos- 
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trum which has been pre-treated with trichloroacetic 
acid contained several active components, a group 
of iso-inhibitors [7]. The question remained open 
whether this micro-heterogeneity is inherent or ac- 
quired during the initial stages of the isolation pro- 
cess. 
To compare the human and bovine inhibitors, we 
tried to isolate the inhibitor from human colostrum 
in an analogical way to that described for the bovine 
inhibitor. Difficulties in the early stage of the isola- 
tion procedure prompted us to reinvestigate some 
properties of proteins responsible for trypsin inhibi- 
tion in the colostrum prior to its treatment with tri- 
chloroacetic acid. This study revealed substantial 
qualitative differences between the human and 
bovine colostrum as regards trypsin inhibition. 
2. Experimental 
The inhibitor was determined by the spectrophoto- 
metric method of Kunitz [8] in 0.1 M phosphate buf- 
fer pH 7.6 at 37” with casein Merck “For Biochemis- 
try” as substrate and /3-trypsin isolated from the com- 
mercial Worthington trypsin TRL [9] as enzyme. The 
concentration of trypsin was determined spectropho- 
tometrically using the absorption coefficient 16.1 
[lOI. 
The inhibitor content of human colostrum from 
2nd and 3rd day varied between 20 and 40 pg of 
trypsin inhibited per ml and it was constant over a 
month in a refrigerator. The inhibitor content of bo- 
vine colostrum from 1st day was 500-600 pg of 
trypsin inhibited per ml. It was constant for at least 
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Fig. 1. Stability of the colostrum inhibitors towards trichloro- 
acetic acid (a) and at different pH values (b). X-X bovine, 
o- human colostrum. Room temperature, incubation time 
30 min (a) and 1 hr (b). 
4 months when the colostrum was stored in a refri- 
gerator. The inhibitor content of the serum from a 
woman in labor was 1.9 mg of trypsin inhibited per 
ml. 
Incubation with trichloroacetic acid: the colos- 
trum was mixed with the same volume of TCA of 
appropriate concentration, samples were evaluated 
for inhibitor content after 30 min of incubation at 
room temperature. In the case of bovine colostrum 
in the range of 1.5-2.5% TCA concentration, fil- 
tration has been found necessary prior to sample 
withdrawal. 
incubation at different pH-values: the colostrum 
was adjusted to an appropriate pH and left for 1 hr 
at room temperature. 100 ~1 of the solution was 
withdrawn for the assay. Bovine colostrum was di- 
luted after pH adjustment ten times with a buffer of 
the same pH. 
Incubation at different temperature: colostrum 
(bovine 10 X diluted) was adjusted to an appropriate 
pH and kept at different temperatures. Samples were 
withdrawn at given times and kept at 0’ prior to the 
assay. 
For the gel chromatography on a Sephadex G-l 00 
column, samples of the human and bovine colostrum 
were centrifuged for 30 min at 2000 rpm at room 
temperature and left for 2 hr in the refrigerator. The 
fat layer was discarded and in the case of human co- 
lostrum the lower liquid was concentrated three times 
by ultrafiltration. The ultrafiltrate was devoid of ac- 
tivity. Serum sample was chromatographed irectly. 
3. Results 
3.1. Stability of the inhibitors towards trichloroacetic 
acid 
Preliminary experiments have shown, that the treat- 
ment of the human colostrum with 2.5% trichloro- 
acetic acid destroys its antitryptic activity complete- 
ly. The comparison of the residual inhibitor activity 
with that of the bovine colostrum at different TCA 
concentrations is shown in fig. la. 
In the human colostrum the presence of the inhibi- 
tor can no more be detected even at a 0.5% TCA con- 
centration which changes the pH value of the colos- 
Table 1 
Residual antitryptic activity of human colostrum incubated 
at different temperatures for 1 hr and at 56” for different 
intervals. At the same conditions the activity of bovine colos- 
trum remained unaltered. 
conditions activity 
pH 4.5 pH 7.6 
22”) 60 min 50 100 
37”, 60 min 25 95 
56”, 60 min 20 60 
10 min, 56” 25 80 
20 min, 56” 25 65 
40 min, 56” 25 70 
60 min, 56” 20 60 
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EFFLUENT, ml 
Fig. 2. Elution patterns of human (a) and bovine (b) colos- 
trum, of serum from pregnant- woman (c) and of standard 
mixture (d). Sephadex G-100 column (1.1 X 110 cm) was 
eluted with a 0.01 M ammonium carbonate buffer pH 8.5, 
fractions 2.2 ml in volume were taken at 45 min intervals. 
Eull tine, absorbance at 280 nm; dashed line, activity in pg 
of trypsin inhibited by 1 ml of the eluate; dotted line, con- 
ductivity. 
trum to 3.5. Only one third of the inhibitor dis- 
appears from the bovine colostrum at about 1% 
TCA, the residual activity does not change at high- 
er TCS concentrations. It follows that in the bovine 
colostrum there exist at least two inhibitors, differ- 
ing in their stability towards TCA. 
3.2. pH and temperature dependence 
To find whether the loss of the inhibitor is due 
specifically to trichloroacetic acid or to the pH 
change, a series of pH dependence assays was under- 
taken (fig. lb). The bovine inhibitor is quite un- 
affected over a broad pH range. In human colostrum 
its concentration decreases below pH 6.0. Still 25% 
of antitrypsin activity remains at pH 3.5 and room 
temperature after 1 hr; a 0.5% TCA concentration 
at this pH caused a total loss of the activity in 30 
min. 
The influence of temperature at different time 
intervals and two pH values is summarized in table 1. 
3.3. Gel chromatography 
Three different fluids containing trypsin inhibi- 
tors were chromatographed under the same condi- 
tions on a Sephadex G-100 column (fig. 2): bovine 
and human colostrum and the serum from a woman 
in latror, containing very high antitrypsin activity 
[ll, 131. 
Only one peak of antitrypsin activity was found 
in the human colostrum. It had the elution volume 
close to that of serum albumin. This volume did not 
change on rechromatography of the pooled peak. The 
activity disappeared entirely in 2.5% trichloroacetic 
acid. 
Bovine colostrum gave three active peaks. The 
first appeared with the dead volume of the column, 
the second was close to the elution volume of serum 
albumin, and the third at a volume corresponding 
approximately to a molecular weight of 22,000. 
In 2.5% TCA at room temperature, the original 
activity of the first and second peak decreased to 
10, resp. 25%, the third peak remained fully active. 
After the TCA treatment, this peak was submitted to 
rechromatography. It emerged from the column at 
the same elution volume as before. 
The serum from a pregnant woman gave two peaks 
of activity, the major one was eluted simultaneously 
with serum albumin. 
4. Discussion 
Both physico-chemical and chemical studies [ 1,6, 
13, 141 have assigned the colostrum inhibitors to 
the class of heat and acid stable inhibitors of low mo- 
lecular weight (6000-10,000). All these studies 
dealt with inhibitors, which have survived the treat- 
ment of the parent colostrum with trichloroacetic 
acid at elevated temperatures. 
From the results presented in this work it follows, 
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that in native bovine colostrum the acid stable in- 
hibitor is’only one of at least three active compo- 
nents of different stability and that in human co- 
lostrum the only active component is destroyed by 
both trichloroacetic acid and heat. 
One of the surprising findings was the low elution 
volume of the TCA stable inhibitor from bovine co- 
lostrum which emerged before the peak of ribonu- 
clease and corresponded to a molecular weight of 
trypsin. There was no activity found in the range 
between the elution volume of ribonuclease and 
basic pancreatic trypsin inhibitor, which served as 
standard proteins in a parallel run. The relation of 
our TCA stable inhibitor to the bovine colostrum 
inhibitors which have been isolated previously by 
the TCA treatment [ 1,7,8] deserves further inves- 
tigation. 
The second inhibitor from the bovine colostrum 
and the only active peak from the human colostruml 
were both inactivated by TCA. The emerged with 
an elution volume close to that of serum albumin 
and of the major inhibitor peak from serum. 
The trypsin inhibitor of human serum, known as 
or -antitrypsin, has a slightly lower molecular weight 
than serum albumin [ 151. It is destroyed by TCA 
[I, 161 and has a low stability below pH 5.5 [l, 
15- 171. It occurs in high concentration in the blood 
of women in labor [ 1 I] 
All the results indicate, that the human colostrum 
inhibitor and the second high molecular weight bo- 
vine colostrum inhibitor resemble more the (II 1 -anti- 
trypsin from human serum than the group of the 
heat and acid stable low molecular weight bovine 
inhibitors. 
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